ArticleFamilial cancer2026

Re-evaluating hereditary breast and ovarian cancer risk: clinical impact of updated multigene panel sequencing and genetic counseling.

Julie Isabelle Plougmann Gislinge et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.